401 - Hematopoietic Stem/Progenitor Cells and Engineering: T-ALLO10 INFUSION AFTER AβDEPLETED-HSCT IN CHILDREN AND YOUNG ADULTS WITH HEMATOLOGIC MALIGNANCIES: IMPROVED IMMUNE RECONSTITUTION IN THE ABSENCE OF SEVERE GVHD.

MLA

Bertaina, A., et al. “401 - Hematopoietic Stem/Progenitor Cells and Engineering: T-ALLO10 INFUSION AFTER AβDEPLETED-HSCT IN CHILDREN AND YOUNG ADULTS WITH HEMATOLOGIC MALIGNANCIES: IMPROVED IMMUNE RECONSTITUTION IN THE ABSENCE OF SEVERE GVHD.” Cytotherapy (Elsevier Inc.), vol. 25, no. 6, May 2023, pp. S123–24. EBSCOhost, https://doi.org/10.1016/S1465-3249(23)00363-8.

APA

Bertaina, A., Bacchetta, R., Shyr, D. C., Saini, G., Lee, J., Kristovich, K., Agarwal, R., Klein, O., Melsop, K., Tate, K., Barbarito, G., Oppizzi, L., Chen, P., Cepika, A., & Roncarolo, M. (2023). 401 - Hematopoietic Stem/Progenitor Cells and Engineering: T-ALLO10 INFUSION AFTER AβDEPLETED-HSCT IN CHILDREN AND YOUNG ADULTS WITH HEMATOLOGIC MALIGNANCIES: IMPROVED IMMUNE RECONSTITUTION IN THE ABSENCE OF SEVERE GVHD. Cytotherapy (Elsevier Inc.), 25(6), S123–S124. https://doi.org/10.1016/S1465-3249(23)00363-8

Chicago

Bertaina, A., R. Bacchetta, D.C. Shyr, G. Saini, J. Lee, K. Kristovich, R. Agarwal, et al. 2023. “401 - Hematopoietic Stem/Progenitor Cells and Engineering: T-ALLO10 INFUSION AFTER AβDEPLETED-HSCT IN CHILDREN AND YOUNG ADULTS WITH HEMATOLOGIC MALIGNANCIES: IMPROVED IMMUNE RECONSTITUTION IN THE ABSENCE OF SEVERE GVHD.” Cytotherapy (Elsevier Inc.) 25 (6): S123–24. doi:10.1016/S1465-3249(23)00363-8.